Toll Free: 1-888-928-9744

MEI Pharma, Inc. - Product Pipeline Review - 2014

Published: Jun, 2014 | Pages: 39 | Publisher: Global Markets Direct
Industry: Pharmaceutical | Report Format: Electronic (PDF)

MEI Pharma, Inc. - Product Pipeline Review - 2014

Summary

Global Markets Direct's, 'MEI Pharma, Inc. - Product Pipeline Review - 2014', provides an overview of the MEI Pharma, Inc.'s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of MEI Pharma, Inc.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides brief overview of MEI Pharma, Inc. including business description, key information and facts, and its locations and subsidiaries
- The report reviews current pipeline of MEI Pharma, Inc.'s human therapeutic division and enlists all their major and minor projects
- The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones 
- Special feature on out-licensed and partnered product portfolio
- The report summarizes all the dormant and discontinued pipeline projects
- Latest company statement 
- Latest news and deals relating to the MEI Pharma, Inc.'s pipeline products

Reasons to buy

- Evaluate MEI Pharma, Inc.'s strategic position with total access to detailed information on its product pipeline
- Assess the growth potential of MEI Pharma, Inc. in its therapy areas of focus
- Identify new drug targets and therapeutic classes in the MEI Pharma, Inc.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
- Develop strategic initiatives by understanding the focus areas of MEI Pharma, Inc. and exploit collaboration and partnership opportunities
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Plan mergers and acquisitions effectively by identifying the most promising pipeline of MEI Pharma, Inc.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
- Explore the dormant and discontinued projects of MEI Pharma, Inc. and identify potential opportunities in those areas
- Avoid Intellectual Property Rights related issues
 Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 4
MEI Pharma, Inc. Snapshot 5
MEI Pharma, Inc. Overview 5
Key Information 5
Key Facts 5
MEI Pharma, Inc. - Research and Development Overview 6
Key Therapeutic Areas 6
MEI Pharma, Inc. - Pipeline Review 9
Pipeline Products by Stage of Development 9
Pipeline Products - Monotherapy 10
MEI Pharma, Inc. - Pipeline Products Glance 11
MEI Pharma, Inc. - Clinical Stage Pipeline Products 11
Phase II Products/Combination Treatment Modalities 11
Phase I Products/Combination Treatment Modalities 12
MEI Pharma, Inc. - Early Stage Pipeline Products 13
Preclinical Products/Combination Treatment Modalities 13
Discovery Products/Combination Treatment Modalities 14
MEI Pharma, Inc. - Drug Profiles 15
pracinostat 15
Product Description 15
Mechanism of Action 15
R&D Progress 15
ME-143 17
Product Description 17
Mechanism of Action 17
R&D Progress 17
ME-344 19
Product Description 19
Mechanism of Action 19
R&D Progress 19
NV-128 21
Product Description 21
Mechanism of Action 21
R&D Progress 21
PWT-143 23
Product Description 23
Mechanism of Action 23
R&D Progress 23
SB-1502 24
Product Description 24
Mechanism of Action 24
R&D Progress 24
MEI Pharma, Inc. - Pipeline Analysis 25
MEI Pharma, Inc. - Pipeline Products by Target 25
MEI Pharma, Inc. - Pipeline Products by Route of Administration 26
MEI Pharma, Inc. - Pipeline Products by Molecule Type 27
MEI Pharma, Inc. - Pipeline Products by Mechanism of Action 28
MEI Pharma, Inc. - Recent Pipeline Updates 29
MEI Pharma, Inc. - Dormant Projects 36
MEI Pharma, Inc. - Locations And Subsidiaries 37
Head Office 37
Appendix 38
Methodology 38
Coverage 38
Secondary Research 38
Primary Research 38
Expert Panel Validation 38
Contact Us 39
Disclaimer 39
List of Tables
MEI Pharma, Inc., Key Information 5
MEI Pharma, Inc., Key Facts 5
MEI Pharma, Inc. - Pipeline by Indication, 2014 8
MEI Pharma, Inc. - Pipeline by Stage of Development, 2014 9
MEI Pharma, Inc. - Monotherapy Products in Pipeline, 2014 10
MEI Pharma, Inc. - Phase II, 2014 11
MEI Pharma, Inc. - Phase I, 2014 12
MEI Pharma, Inc. - Preclinical, 2014 13
MEI Pharma, Inc. - Discovery, 2014 14
MEI Pharma, Inc. - Pipeline by Target, 2014 25
MEI Pharma, Inc. - Pipeline by Route of Administration, 2014 26
MEI Pharma, Inc. - Pipeline by Molecule Type, 2014 27
MEI Pharma, Inc. - Pipeline Products by Mechanism of Action, 2014 28
MEI Pharma, Inc. - Recent Pipeline Updates, 2014 29
MEI Pharma, Inc. - Dormant Developmental Projects,2014 36 



                                

To request a free sample copy of this report, please complete the form below.

We never share your personal data. Privacy policy
Interested in this report? Get your FREE sample now! Get a Free Sample
Choose License Type
Single User - US $1500
Multi User - US $3000
Hexareeasearch Know

Did you know?

Research Assistance

Phone: 1-415-349-0054

Toll Free: 1-888-928-9744

Email: [email protected]

Why to buy from us

Custom research service

Speak to the report author to design an exclusive study to serve your research needs.

Information security

Your personal and confidential information is safe and secure.

verify